Kunlun Capital
Beijingkunlun-cap.com
Overview
Kunlun Capital is an investment management institution affiliated with the Kunlun Wanwei Group that focuses on investing in technology innovation enterprises. It invests in both primary and secondary markets with a focus on the high-tech, healthcare, and consumer sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Shanghai UniXell Biotechnology | Apr 2025 | Series A | Co-investor |
| 北京中因科技有限公司 | Oct 2023 | Series A Extension | Lead |
| Zhejiang NaTRIUM Energy Co., Ltd. | Feb 2023 | Series A Extension | Co-investor |
| Hangzhou Microquanta Semiconductor Co., Ltd. | Oct 2022 | Series D | Co-investor |
| Shanghai CirCode Biomed Co. Ltd. | Dec 2021 | Pre Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
